Citigroup’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Buy |
|
|||||
|
2025
Q1 | $324K | Sell |
|
|||||
|
2024
Q4 | $405K | Buy |
|
|||||
|
2024
Q3 | $357K | Buy |
|
|||||
|
2024
Q2 | $140K | Buy |
|
|||||
|
2024
Q1 | $72.6K | Sell |
|
|||||
|
2023
Q4 | $280K | Buy |
|
|||||
|
2023
Q3 | $5.69K | Sell |
|
|||||
|
2023
Q2 | $64.4K | Sell |
|
|||||
|
2023
Q1 | $507K | Buy |
|
|||||
|
2022
Q4 | $484K | Buy |
|
|||||
|
2022
Q3 | $3K | Sell |
|
|||||
|
2022
Q2 | $6K | Sell |
|
|||||
|
2022
Q1 | $11K | Sell |
|
|||||
|
2021
Q4 | $53K | Buy |
|
|||||
|
2021
Q3 | $58K | Buy |
|
|||||
|
2021
Q2 | $35K | Buy |
|
|||||
|
2021
Q1 | $34K | Sell |
|
|||||
|
2020
Q4 | $80K | Buy |
|
|||||
|
2020
Q3 | $43K | Sell |
|
|||||
|
2020
Q2 | $183K | Buy |
|
|||||
|
2020
Q1 | $121K | Buy |
|
|||||
|
2019
Q4 | $180K | Buy |
|
|||||
|
2019
Q3 | $35K | Sell |
|
|||||
|
2019
Q2 | $206K | Buy |
|
|||||
|
2019
Q1 | $11K | Buy |
|